BRD4 disorders have been implicated in the pathogenesis of many cancers, such as AML, multiple myeloma, Burkitt’s lymphoma, diffuse large B-cell lymphoma, and breast, colon, and ovarian cancers (117, 125–130). This evidence concerns the gene BRD4 and ovarian cancer.